Johnson & Johnson Begins Two-Dose Phase 3 Trial Of COVID-19 Vaccine
November 16, 2020 at 06:22 AM EST
Johnson & Johnson has started the two-dose Phase 3 trial of its experimental COVID-19 vaccine, dubbed "ENSEMBLE 2," the pharmaceutical company announced Sunday.